tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Jiangsu Hengrui Pharmaceuticals Approves Resolutions at 2025 Shareholders’ Meeting
PremiumCompany AnnouncementsJiangsu Hengrui Pharmaceuticals Approves Resolutions at 2025 Shareholders’ Meeting
3M ago
Positive Buy Rating for Jiangsu Hengrui Pharmaceuticals Driven by Strategic Out-Licensing and Promising HRS-1893 Data
Premium
Ratings
Positive Buy Rating for Jiangsu Hengrui Pharmaceuticals Driven by Strategic Out-Licensing and Promising HRS-1893 Data
3M ago
Jiangsu Hengrui Pharmaceuticals Licenses Innovative Drug to Braveheart Bio
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Licenses Innovative Drug to Braveheart Bio
3M ago
Jiangsu Hengrui Pharmaceuticals Reports Strong Interim Results for 2025
PremiumCompany AnnouncementsJiangsu Hengrui Pharmaceuticals Reports Strong Interim Results for 2025
4M ago
Jiangsu Hengrui Pharmaceuticals Approves 2025 Employee Stock Ownership Scheme
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Approves 2025 Employee Stock Ownership Scheme
4M ago
Jiangsu Hengrui Pharmaceuticals Announces Upcoming Board Meeting for Interim Results
Premium
Company Announcements
Jiangsu Hengrui Pharmaceuticals Announces Upcoming Board Meeting for Interim Results
4M ago
Jiangsu Hengrui Pharmaceuticals Completes Over-allotment Option in Global Offering
PremiumCompany AnnouncementsJiangsu Hengrui Pharmaceuticals Completes Over-allotment Option in Global Offering
6M ago
Jiangsu Hengrui Gains Approval for Innovative Cancer Drug
Premium
Company Announcements
Jiangsu Hengrui Gains Approval for Innovative Cancer Drug
6M ago
Jiangsu Hengrui’s Innovative Antiemetic Drug Gains Approval
Premium
Company Announcements
Jiangsu Hengrui’s Innovative Antiemetic Drug Gains Approval
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100